Invictus MD: Underappreciated Among Licensed Producers


Ryan Allway

September 25th, 2017

Exclusive, News, Top News


Canada’s cannabis industry is projected to surpass C$22.6 billion over the coming years, according to Deloitte, driven by the legalization of recreational marijuana next year. Despite more than 50 approved licensed producers, many analysts expect that the market will experience a near-term shortfall in production as consumer demand soars. Existing licensed producers have responded by rapidly increasing their capacity.

Most investors are familiar with Canopy Growth Corp. (TSX: WEED) and Aurora Cannabis Inc. (TSX-V: ACB) (OTC: ACBFF), but there’s one emerging licensed producer that has been underappreciated by the market – Invictus MD Strategies Corp. (TSX-V: IMH) (OTC: IVITF) (FRA: 8IS1).

In this article, we will take a closer look at the market and why Invictus MD Strategies could represent a compelling opportunity for investors.

Existing Production Levels

Health Canada has approved nearly 60 licensed producers, but the approval process is very costly, time-consuming, and rigorous. Many licensed producers have only been licensed to cultivate relatively small amounts of dried cannabis of less than 10,000 kilograms per year. While some of these licensed producers have been rapidly expanding their footprint, many of these deals are contingent on financing that may be uncertain.

Company License (kg) Production (kg) Space (sq. ft.)
Canopy Growth Corp. 21,100 22,300 500,000+
Aurora Cannabis Inc. 5,400 3,000 55,200
Aphria Inc. 8,000 2,952 22,000

* Data from most recent MD&A filings with SEDAR.

Despite limited production and revenue, many of these companies have achieved lofty valuations by traditional measures. For example, Canopy Growth trades with a market capitalization of C$1.76 billion despite generating just C$40 million in revenue and generating a net loss of C$17 million. Investors are valuing the stock at nearly $80,000 per kilogram of production in the hopes that its future growth pays off.

Invictus MD’s Potential

Invictus MD Strategies’ cannabis cultivation activities are divided between its wholly-owned Acreage Pharms Ltd. subsidiary, its 33.3% ownership in AB Laboratories Inc., and its 33.3% ownership in AB Ventures Inc. With $28.5 million in cash on its balance sheet, the company has sufficient capital to finance the build out of 148,350 square feet of cultivation space capable of generating 15,142 net kilograms of cannabis each year (after accounting for its partial interest).

Source: Invictus MD Investor Deck

Acreage Pharms

Acreage Pharms Ltd. has an existing 6,800 sq. ft. purpose built concrete and steel facility on a 150-acre property with the capacity to produce 609 kilograms of cannabis per year.

In its fully-funded Phase II expansion, Acreage Pharms plans to build a 27,800 sq. ft. purpose built concrete and steel facility with the capacity to produce 4,200 kilograms per year. The facility is fully permitted and fully financed with construction underway, which sets it apart from many licensed producers that have less concrete plans. Management anticipates that the facility will be completed by January 2018 in time for recreational legalization.

In its fully-funded Phase III expansion, Acreage Pharms plans on building a 76,750 sq. ft. facility capable of producing 9,000 kilograms of cannabis per year. The $16.5 million project is expected to be completed by June 2018, subject to necessary permitting.

AB Laboratories

AB Laboratories has an existing 16,000 square foot purpose built concrete and steel facility capable of producing 1,000 kilograms of cannabis per year. Considering the ⅓  ownership interest, this translates to 333 kilograms per year net to Invictus.

AB Ventures

In its $5.5 million Phase I expansion, the company plans to expand 21,000 square feet by the end of 2017 to add 3,000 kilograms of cannabis capacity per year, subject to permitting. In the same phase of expansion, AB Ventures expects to build the exterior of a second 21,000 square foot facility.

Future Expansion

The company estimates that another $47.5 million capital injection could help it achieve 50,000 kilograms per year of production. This could be well within reach given that it could see $44 million in capital from warrants being exercised alone.

Looking Ahead

Invictus MD Strategies Corp. (TSX-V: IMH) (OTC: IVITF) (FRA: 8IS1) represents a compelling opportunity in the legal cannabis industry. With a market capitalization of just $94 million Canadian, the company trades significantly lower than many other licensed producers, particularly given that its expansion projects are fully-financed and already underway. Investors may want to take a closer look at the stock given these dynamics.

For more information, visit the company’s website or investor presentation.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading